Dashboard
Manage Tickers

DRNADicerna Pharmaceuticals Inc

Nasdaq www.dicerna.com


$ 38.23 $ 0.22 (0.58 %)    

Monday, 27-Dec-2021 15:59:57 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 38.22
$ 38.22 x 207
$ 38.23 x 1,100
-- - --
$ 19.06 - $ 40.14
5,568,959
na
2.97B
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-09-2021 09-30-2021 10-Q
2 08-09-2021 06-30-2021 10-Q
3 05-06-2021 03-31-2021 10-Q
4 02-26-2021 12-31-2020 10-K
5 11-05-2020 09-30-2020 10-Q
6 08-06-2020 06-30-2020 10-Q
7 05-07-2020 03-31-2020 10-Q
8 02-28-2020 12-31-2019 10-K
9 11-07-2019 09-30-2019 10-Q
10 08-08-2019 06-30-2019 10-Q
11 05-10-2019 03-31-2019 10-Q
12 03-13-2019 12-31-2018 10-K
13 11-05-2018 09-30-2018 10-Q
14 08-08-2018 06-30-2018 10-Q
15 05-14-2018 03-31-2018 10-Q
16 03-08-2018 12-31-2017 10-K
17 11-02-2017 09-30-2017 10-Q
18 08-10-2017 06-30-2017 10-Q
19 05-08-2017 03-31-2017 10-Q
20 03-30-2017 12-31-2016 10-K
21 11-07-2016 09-30-2016 10-Q
22 08-04-2016 06-30-2016 10-Q
23 05-09-2016 03-31-2016 10-Q
24 03-10-2016 12-31-2015 10-K
25 11-10-2015 09-30-2015 10-Q
26 08-06-2015 06-30-2015 10-Q
27 05-11-2015 03-31-2015 10-Q
28 03-12-2015 12-31-2014 10-K
29 11-06-2014 09-30-2014 10-Q
30 08-07-2014 06-30-2014 10-Q
31 05-13-2014 03-31-2014 10-Q
32 03-27-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-biggest-price-target-changes-for-thursday
10 Biggest Price Target Changes For Thursday
12/09/2021 15:28:21

SVB Leerink boosted the price target on Edwards Lifesciences Corporation (NYSE: EW) from $130 to $135. Edwards Lifesciences...

benzingas-top-ratings-upgrades-downgrades-for-december-9-2021
Benzinga's Top Ratings Upgrades, Downgrade...
12/09/2021 15:27:20

Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:NVEI) was changed from Market Perform to Outperform.

chardan-capital-downgrades-dicerna-pharmaceuticals-to-neutral-raises-price-target-to-3825
Chardan Capital Downgrades Dicerna Pharmac...
12/09/2021 10:01:44

Chardan Capital analyst Keay Nakae downgrades Dicerna Pharmaceuticals (NASDAQ:DRNA) from Buy to Neutral and raises the price...

dicerna-pharmaceuticals-option-alert-jan-21-35-calls-sweep-4-near-the-ask-497--35-vs-6158-oi-ref3807
Dicerna Pharmaceuticals Option Alert: Jan ...
12/02/2021 17:58:29

dicerna-pharma-block-trade-of-500k-shares-at-38share
Dicerna Pharma Block Trade Of 500K Shares ...
11/24/2021 20:55:02

benzingas-top-ratings-upgrades-downgrades-for-november-19-2021
Benzinga's Top Ratings Upgrades, Downgrade...
11/19/2021 15:08:55

 

54-biggest-movers-from-yesterday
54 Biggest Movers From Yesterday
11/19/2021 11:19:40

Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted...

rbc-capital-downgrades-dicerna-pharmaceuticals-to-sector-perform-raises-price-target-to-3825
RBC Capital Downgrades Dicerna Pharmaceuti...
11/19/2021 10:45:34

RBC Capital analyst Luca Issi downgrades Dicerna Pharmaceuticals (NASDAQ:DRNA) from Outperform to Sector Perform and raises ...

mid-afternoon-market-update-dow-falls-75-points-dicerna-pharmaceuticals-shares-spike-higher
Mid-Afternoon Market Update: Dow Falls 75 ...
11/18/2021 19:31:57

Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&...

novartis-has-21b-from-roche-stake-sale---which-company-is-on-its-ma-radar
Novartis Has $21B From Roche Stake Sale - ...
11/18/2021 19:23:18

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
11/18/2021 17:38:17

 

mid-day-market-update-macys-surges-after-q3-results-amtech-systems-shares-plunge
Mid-Day Market Update: Macy's Surges After...
11/18/2021 17:33:00

Midway through trading Thursday, the Dow traded down 0.52% to 35,745.78 while the NASDAQ fell 0.22% to 15,886.57. The S&P a...

44-stocks-moving-in-thursdays-mid-day-session
44 Stocks Moving In Thursday's Mid-Day Ses...
11/18/2021 17:23:46

Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designa...

hc-wainwright--co-downgrades-dicerna-pharmaceuticals-to-neutral-raises-price-target-to-3825
HC Wainwright & Co. Downgrades Dicerna Pha...
11/18/2021 16:55:02

HC Wainwright & Co. analyst Ed Arce downgrades Dicerna Pharmaceuticals (NASDAQ:DRNA) from Buy to Neutral and raises the ...

mid-morning-market-update-markets-down-kohls-earnings-top-expectations
Mid-Morning Market Update: Markets Down; K...
11/18/2021 15:21:07

Following the market opening Thursday, the Dow traded down 0.70% to 35,678.02 while the NASDAQ fell 0.36% to 15,863.49. The S&a...

novo-nordisk-swallows-dicerna-in-33b-buyout-all-you-need-to-know
Novo Nordisk Swallows Dicerna In $3.3B Buy...
11/18/2021 14:28:16

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
11/18/2021 13:38:55

 

dicerna-shares-resume-trade-up-77
Dicerna Shares Resume Trade, Up ~77%
11/18/2021 12:35:24

Core News & Articles
Novo Nordisk To Acquire Dicerna For $38.25...
11/18/2021 12:01:25

dicerna-highlights-presentation-of-data-from-phase-1-trial-of-belcesiran-at-american-association-for-the-study-of-liver-diseases-aasld-the-liver-meeting-2021
Dicerna Highlights Presentation Of Data Fr...
11/12/2021 13:01:46

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION